A fundamental goal of regenerative medicine is to replace fibrosis and scarring in damaged mammalian tissues with functional tissue. Thus far there has been very little progress towards this goal because of a lack of an adult mammalian model system that demonstrates functional regeneration, and instead the typical response of damaged mammalian skin is to form a hairless, collagenous scar. However, recent studies revealed that African spiny mouse (Acomys), following full thickness skin removal, can regenerate all the tissues removed: the epidermis, hair, sebaceous glands, erector pili muscles, dermis and skeletal muscle of the panniculus carnosus, all without scarring. In our experiments to date characterizing the differences between regenerating Acomys skin wounds and scarring Mus skin wounds, we have identified many molecular differences but we have no real handle on what exactly are responsible for regeneration vs scarring. To reveal molecular mechanisms underlying this remarkable capacity of Acomys to regenerate normal tissue, the scientific community needs a way to modify genes in the animals. For instance, we previously identified that collagen type III is particularly abundant in Acomys skin regeneration, whereas Mus exhibits a much higher ratio of collagen type I to type III during wound scarring1. However, we do not know that how this abundant collagen type III plays a role in a higher regenerative capacity of Acomys. In the present proposal, we will knockout the Col3a1 gene within Acomys fibroblasts as well as the whole animals as an exemplar with which to study the role of specific genes in higher wound repair capacity of the animal. The establishment of an efficient gene editing method with Acomys will open a revolutionary new avenue for mammalian regeneration research.

Public Health Relevance

Spiny mouse can perfectly regenerate its skin and replace hairs, sebaceous glands, dermis, smooth and skeletal muscle all without scarring. The typical response of all other mammals to skin wounding is to fibrose and form a hairless scar. Here we will establish a system to identify what gene is responsible for regenerative properties. Once we establish an efficient gene editing method within Acomys, the present study will open a new avenue for mammalian regeneration research.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21OD028211-02
Application #
10015365
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Zou, Sige
Project Start
2019-09-15
Project End
2021-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Florida
Department
Pathology
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611